Abstract
Common features seen in the early stages of many neurodegenerative diseases include increases in oxidative stress and mitochondrial dysfunction, ultimately leading to defects in cellular energy production. These changes particularly affect cells that are highly active, such as neurons. As such, reduced synaptic transmission is a common early feature associated with neurodegenerative diseases, such as Parkinson s disease, Alzheimer s disease, Huntington s disease and Amyotrophic Lateral Sclerosis. Many genes associated with neurodegenerative diseases are now known to regulate either mitochondrial function, redox state or the exocytosis of neurotransmitters. Mitochondria are a significant source of cellular ATP and reactive oxygen species and are prevalent in synapses at areas of exocytosis. Therefore, it follows that reductions in mitochondrial function and/or increases in oxidative stress will impact on neurotransmission.
Similar content being viewed by others
Keywords
- Mitochondria
- Oxidative stress
- Exocytosis
- Neurotransmission
- Synaptic transmission
- SNARE proteins
- Long-term potentiation
- β-amyloid
- Alzheimer s disease
- Parkinson s disease
- Amyotrophic lateral sclerosis
- Huntington s disease
1 Introduction
It is important to recognize that neurodegenerative disorders involve not only loss of neurons, but significant dysfunction in select populations of remaining neurons. This impaired function of remaining but injured neurons manifests in disruption of neurotransmission. This chapter describes the impact of oxidative stress and deficits in cellular energy and mitochondrial function on neurotransmission, particularly in the context of neurodegenerative disease. A functional window into neural injury enables elucidation of early injuries. The roles these deficits are thought to play in the early aetiology of several neurodegenerative diseases are highlighted. The theory underlying pertinent techniques used to study exocytosis and neurotransmission and the application of these techniques in the study of neurodegenerative disease are also described.
2 Synaptic Transmission, Oxidative Stress and Mitochondrial Dysfunction
2.1 Gene Responses to Normal Ageing in the Brain
While the factors underlying cognitive decline in both normal ageing and neurodegenerative diseases are not clearly understood, reductions in the amount and efficiency of synaptic transmission are obvious focal points. Synaptic transmission decreases during normal ageing [1, 2] and in the early stages of disease pathology in animal models of some neurodegenerative diseases [3–8]. A postmortem analysis of gene expression in the frontal cortex of human subjects aged 26–106 revealed that the expression of genes involved in synaptic plasticity, vesicular transport and mitochondrial function decrease after 40 years of age [9]. However, genes involved in the stress response, antioxidation and DNA repair are induced after 40 years of age [9]. DNA damage is also markedly increased in the promoters of genes that show reduced expression in the aged cortex and these same genes are less capable of undergoing DNA repair [9].
2.2 Oxidative Injury in Normal Ageing with Impact on Synaptic Transmission
Oxidative damage is a likely contributing factor to the cognitive decline that accompanies ageing. Mitochondrial dysfunction, amounts of reactive oxygen species (ROS) and prolonged periods of oxidative stress increase with age (reviewed in [10]). Sources of ROS, in the form of O2 • –, and hence ultimately oxidative stress, include mitochondria, NADPH oxidase, xanthine oxidase and P450 oxidase. Throughout this text, the term ROS will be used in reference to hydrogen peroxide (H2O2). The usual reference is to the superoxide anion (O2 • ), which is produced during the reduction of O2 to water in the mitochondrial electron transport chain. As O2 • − is spontaneously or enzymatically converted to H2O2 at rapid rates, the term ROS usually refers ultimately to H2O2, as it is far more long-lived than O2 • − within cells.
Increasing amounts of ROS have been attributed to impairing long-term potentiation (LTP), an increase in the strength of a neuronal synapse, in hippocampal area CA1 in an age-related manner as determined by measuring excitatory postsynaptic potentials (EPSPs) from hippocampal slices [1, 11]. Hippocampal slices from older rats produce more H2O2 than younger rats (reviewed in [12]) and age is associated with decreases in the hippocampal concentration of vitamins C and E and increased activity of superoxide dismutase [13]. The concentrations of ROS applied to these slices have differential effects on LTP. For example, low concentrations (1 μM) of H2O2 potentiate LTP in hippocampus of young rats by up to two-fold by affecting internal calcium (Ca2+) stores [14]. However, high concentrations (20 μM or above) of H2O2 impair synaptic transmission and LTP via calcineurin-dependent mechanisms [14]. These findings indicate that optimal amounts of ROS are required for the highest levels of LTP to occur and too few or too many ROS are detrimental to synaptic transmission. The requirement for an optimal amount of ROS is also evident in other aspects of normal cellular function, such as the regulation of neuronal excitability via redox-sensitive ion channels [15–18], synaptic plasticity [12], gene transcription [19], multiple signal transduction pathways [19] and the activity of enzymes controlling protein phosphorylation [20].
2.3 Redox Regulation of Exocytosis
The synaptic fusion machinery can be directly and acutely regulated by redox state. This was illustrated in frog and mouse motor nerve endings, where evoked and spontaneous quantal release was reduced by physiological levels of ROS [21]. Antioxidants also increased the quantal level of release, consistent with the tonic inhibition of exocytosis by endogenous levels of ROS [21]. The use of a Ca2+ ionophore subsequently revealed that this effect of ROS was due to action directly on the fusion machinery [21]. Subsequent investigations established that some SNARE proteins are sensitive to oxidative stress, SNAP-25 being the most sensitive of those studied [21]. Specific cysteine residues in SNAP-25 are required for SNARE disassembly and exocytosis but not for membrane targeting [22]. As cysteine residues are commonly affected by redox state, crucial alterations in SNAP-25 structure may underlie the lack of SNARE complex assembly and reduced exocytosis seen in motor nerve endings during conditions of oxidative stress. Interestingly, the expression of some exocytotic proteins, including SNARE proteins, is altered in disease-relevant brain areas in neurodegenerative diseases such as AD and HD [23, 24]. Therefore, the redox modulation of SNARE complex formation is a mechanism by which mitochondrial dysfunction occurring early in some neurodegenerative diseases might reduce synaptic activity.
2.4 Energy-Dependence of Exocytosis
Certain steps in the exocytotic pathway are also regulated by ATP in the cell. The two major ATP-regulated steps in exocytosis have been identified as a reversible ATP-dependent priming of docked granules, which is followed by a second, Ca2+-dependent step involving vesicle fusion and the release of vesicle contents [25, 26]. The ATP-dependent step comprises both vesicle recruitment to the plasma membrane and vesicle priming [27, 28]. The role of ATP here is to enable the phosphorylation of phosphatidylinositol groups via phosphatidylinositol kinases localized to both vesicle and plasma membranes. These kinases include phosphatidylinositol-4-phosphate 5-kinase [29], phosphatidylinositol 4-kinase [30] and phosphatidylinositol 3-kinase C2α [31]. While there is some association between neurodegenerative diseases and the effects of ATP on exocytosis, most of this evidence is indirect. An example of this is the overexpression of the PD-associated protein α-synuclein inhibiting a vesicle-priming step prior to Ca2+-dependent vesicle fusion but after secretory vesicle trafficking to docking sites [32]. While it is unknown how this inhibition occurs, the step at which it takes place is also where ATP-dependent priming occurs.
Two recent independent studies on Drosophila mutants with synapses containing few or no mitochondria support the hypothesis that proper synaptic mitochondrial ATP production is vital for normal synaptic transmission and that mitochondria play a specific role in regulating synaptic strength [33, 34]. Flies with loss-of-function mutations in dynamin-related protein (drp), which is implicated in the fission of the outer mitochondrial membrane, display almost no synaptic mitochondria. These animals sometimes develop into adult flies and the mitochondria in cell bodies remain functional, allowing the role of synaptic mitochondria in neurotransmission to be assessed. In the neuromuscular junction of these mutants, resting Ca2+ levels are slightly increased and basal synaptic properties are hardly altered. However, during intense stimulation, normal neurotransmission cannot be maintained [34]. This is not due to alterations in the kinetics of vesicle fusion or fission, but rather stems from a reduced ability to mobilize the reserve pool of vesicles, an effect that is partially rescued by exogenous ATP [34].
Drosophila mutants of Miro (dmiro), a mitochondrial GTPase with an essential role in mitochondrial trafficking, exhibit defects in locomotion and die prematurely [33]. Neuronal and muscular mitochondria in dmiro mutants are not transported into axons and dendrites but accumulate in neuronal somata. Similarly to drp mutants, dmiro mutants only display changes in neurotransmission during prolonged stimulation [33]. Given the considerable reduction in synaptic mitochondria, it might be presumed that amounts of ROS would be considerably reduced in these mutants. As previously stated, a significant reduction in ROS can be detrimental to multiple facets of neuronal function. Unfortunately, neither of the studies mentioned [33, 34] measured synaptic ROS levels in these mutant flies, so assessment of the separate effect of mitochondrial ATP and ROS on neurotransmission in this setting cannot be made. However, these studies highlight the requirement for synaptic mitochondrial ATP during periods of intense activity for the recruitment and transport of vesicles from the reserve vesicle pool (Fig. 1).
3 Neurodegenerative Disorders
There is extensive evidence supporting a role for mitochondrial dysfunction and oxidative stress in the pathogenesis of multiple neurodegenerative disorders and in animal models of these diseases. Mitochondria are significantly more likely to be localized at synaptic sites [35] and the speed of mitochondrial motility is greatest in younger, developing neurons [36]. Mitochondria are increasingly localized to dendritic spines during early developmental stages or following repeated stimulation [37]. This mitochondrial localization is necessary for the normal development and morphological plasticity of dendritic spines [37]. The following section describes studies that provide evidence for roles of mitochondrial dysfunction, oxidative stress and cell signalling in the early aetiologies of some neurodegenerative diseases.
3.1 Alzheimer s Disease
In human Alzheimer s disease (AD) patients, signs of oxidative damage are observed earlier in the disease course than the characteristic plaques [38]. Similar observations were also made in transgenic amyloid precursor protein (APP) mice, in which the upregulation of genes involved in mitochondrial metabolism and apoptosis precede Aβ deposition [39, 40]. Oxidative stress may be a causative agent of AD as it induces the intracellular accumulation of Aβ. Secretion of neuronal Aβ into the extracellular space is positively correlated with synaptic activity [41–43] and intraneuronal Aβ accumulation is linked with early electrophysiological, synaptic and pathological abnormalities (reviewed in [44]). Intracellular Aβ accumulation is reduced by antibodies against Aβ in transgenic mice [45] and this reduction currently provides the best correlate for improving cognitive function [46]. It is possible that Aβ accumulation caused by oxidative stress is due to reduced exocytosis from neurons. Various mouse models of AD manifest synaptic dysfunction, including LTP deficits, well before classical pathologies such as neurodegeneration and plaque and tangle formation are evident [3, 6, 7]. Similar results are also seen in nonmammalian models of AD, such as in Drosophila, where the deletion or overexpression of the Drosophila APP orthologue, App-like gene, results in reduced axonal transport of synaptic vesicles [47].
3.2 Parkinson s Disease
Mitochondrial dysfunction and vesicular abnormalities have also been implicated in Parkinson s disease (PD). Several genes associated with PD have roles in mitochondrial function, such as Parkin and PINK-1. The inhibition of complex I of the mitochondrial electron transport chain has been shown to cause widespread neuronal damage [48]. This damage includes PD-like pathology, such as nigrostriatal dopaminergic degeneration and α-synuclein-positive cytoplasmic inclusions [48]. The mechanisms underlying these changes are thought to involve oxidative stress [49].
The role of α-synuclein, a presynaptic protein, is thought to be central in PD pathogenesis. However it remains unclear exactly what role α-synuclein plays in the development of PD. In transgenic mice overexpressing α-synuclein, mitochondrial function is impaired, oxidative stress is increased and nigral degeneration, induced by inhibitors of mitochondrial complex I, is enhanced [50]. α-synuclein at normal expression levels appears to be neuroprotective in nondopaminergic human cortical neurons but induces apoptosis when overexpressed in the dopaminergic neurons affected in PD [51]. Ablation or reduction of α-synuclein expression reduces transmitter release, LTP and the size of vesicle pools [32, 52, 53]. Mice overexpressing a dominant-negative mutation of α-synuclein exhibit decreased dopamine release in response to prolonged stimulation [54, 55]. However, while the mutations in α-synuclein that cause genetic forms of PD are clinically of interest, no clear evidence has been published to clearly illustrate that cellular levels of free α-synuclein are increased or decreased in PD brains and thus it is difficult to assess exactly what role α-synuclein plays in the pathogenesis of sporadic forms of PD.
Parkin, a PD-related ubiquitin ligase, is thought to be protective of mitochondria. In Parkin-null mice, oxidative stress and mitochondrial dysfunction are evident [56]. Parkin also seems to be susceptible to oxidative stress, as S-nitrosylation of Parkin reduces its ubiquitin-ligase activity as well as its protective function [57]. Similar effects are also seen in vivo in a mouse model of PD and in the brains of patients with PD [57]. PD mouse models exhibit various alterations in dopaminergic neuronal function prior to the degeneration of dopaminergic brain areas [55, 58, 59].
The role of PINK-1 has also been studied using PINK-1 null mice. The numbers of dopaminergic neurons and dopamine content in the striatum are unaltered in PINK-1 null mice [60]. However, evoked dopamine release from striatal slices is reduced, as is LTP in striatal medium spiny neurons, the main target of dopaminergic neurons [60]. These results, and those mentioned previously, indicate that altered dopaminergic exocytosis may be a pathogenic precursor to nigrostriatal degeneration in PD.
3.3 Amyotrophic Lateral Sclerosis
Amyotrophic Lateral Sclerosis (ALS), commonly known as motor neuron disease, is another neurodegenerative disease with a mitochondrial and oxidative stress component. Mutations in the Cu/Zn-superoxide dismutase gene account for approximately 20% of familial ALS (FALS) cases. Spinal cords and brains obtained from mice that overexpress a SOD1 mutation (G93A) found in some FALS patients display defects in mitochondrial respiration, electron transfer chain activity and ATP synthesis. Signs of oxidative damage to mitochondrial proteins and lipids, indicative of oxidative stress at the time of disease onset, are also evident [61]. Changes in mitochondrial function are seen before this stage though, as mitochondria in the spinal cord and brain display reduced Ca2+ loading ability in these mice [62]. Mitochondria in the proximal axons of anterior horn neurons also appear to be aberrantly localized to the axon hillock in sporadic ALS patients and mouse models of ALS [63, 64]. This was observed in transgenic mice expressing the G93A mutant human SOD1 during presymptomatic stages, indicating that alterations in mitochondrial localization may occur prior to the onset of ALS [64]. Early changes in synaptic transmission are also seen in mouse models of ALS prior to the onset of neurodegeneration [65, 66].
3.4 Huntington s Disease
Huntington s Disease (HD) is also thought to have a mitochondrial component. In neurons of huntingtin knock-in mice, ATP production and mitochondrial respiration are decreased [67], as are the activities of complexes I and III of the electron transport chain in human HD brain samples [68]. These effects may be caused by direct interaction of the huntingtin gene with mitochondria. Mutant huntingtin is localized to neuronal mitochondrial membranes and incubation of mutant huntingtin with normal mitochondria results in depolarization of the mitochondrial membrane at lower Ca2+ loads. This defect has also been observed in mitochondria obtained from HD patients and mice that transgenically overexpress mutant huntingtin [69].
Huntingtin is involved in axonal trafficking in mammals and mutant huntingtin impairs the in vitro and in vivo trafficking of vesicles and mitochondria in mammalian neurons [70]. Importantly, these changes are seen prior to the development of observed neurological abnormalities [70], implying a possible causative role for this altered mitochondrial localization in axons in HD. Huntingtin also interacts with the transcription factor p53 [71], which is known to regulate genes that are responsive to oxidative stress as well as genes which regulate mitochondrial function. In both Drosophila and mouse models of HD, p53 has been found to link nuclear and mitochondrial pathologies characteristic of HD [72]. Altered synaptic plasticity in the R6/2 mouse model of HD occurs prior to the more overt disease phenotypes [5], indicating that synaptic pathology also occurs early in this disease.
4 Methods Used to Study Exocytosis
The following sections attempt to provide a detailed explanation of some of the more common techniques used in the study of exocytosis and synaptic transmission. These methods are relevant to many of the studies mentioned in this chapter. Along with an explanation of the methodology itself, we have also attempted to profile the pros and cons associated with the use of individual techniques and the types of preparations they can be applied to.
4.1 Carbon Fibre Amperometry and Cyclic Voltammetry
Carbon fibre amperometry is a technique used to detect exocytosis in cells that secrete oxidizable molecules such as adrenaline, noradrenaline, dopamine and serotonin. It involves placing a carbon fibre electrode on a single cell in culture or in a brain slice preparation. The cell is then stimulated to trigger exocytosis, releasing vesicle contents that are then oxidized upon contact with the charged carbon fibre electrode. This oxidation results in a flow of current which can be recorded as an amperometric spike (Fig. 2A).
Amperometry is useful as it is noninvasive and does not alter the intracellular environment. It is possible to visualize single exocytotic events providing the stimulus to the cell is not too great and does not cause overlap of individual amperometric spikes. This allows the shape of individual spikes to be studied, providing insight into the kinetic parameters of individual fusion events. Such parameters include the amount of transmitter released from a single vesicle, the speed of fusion pore opening and closing and the kinetics associated with the formation of the transient fusion pore.
Studies of exocytosis using amperometry have shown that, in addition to the classical model of full collapse fusion, where the vesicle membrane fully collapses into the plasma membrane, transient fusion events occur that also result in secretion [73–75]. Amperometry has also provided insight into the kinetics of vesicle fusion and the mechanisms behind it in a diverse array of cell types, including chromaffin cells, dopaminergic neurons, PC12 cells and pancreatic β-cells [76–80]. Whilst pancreatic β-cells do not secrete endogenous compounds which can be oxidized, they can be loaded with a ‘false oxidizable transmitter such as dopamine. However, in our experience, this loading of false transmitter works poorly and is highly unreliable.
Amperometry is limited to cells that secrete oxidizable molecules and by the geometry of the electrode and the cell, as exocytotic events will only be detected when they occur within the proximity of the electrode. This necessitates the use of large sample sizes to reduce the random effects of signal diffusion from exocytotic events more distant from the electrode and also due to the Gaussian distribution of vesicle size within a cell. Amperometry has been utilized in the studies described in this section to assess the effects of PINK1 inactivation on catecholamine release from dissociated adrenal chromaffin cells and the release of dopamine from acute striatal slices obtained from PINK1 −/− mice [60]. Amperometry has also been used to study secretion from dissociated chromaffin cells isolated from mice overexpressing α-synuclein [32].
It is not possible to determine the identity of the molecules secreted from cells using carbon fibre amperometry. This information is discernable using a similar technique called cyclic voltammetry, which involves constantly scanning the electrical potential of the electrode through a range of voltages [80]. The identity of the molecule is determined according to the potential at which it is oxidized or reduced [80]. Cyclic voltammerty has been used to study dopamine release from neurons in vivo, in mice where the human α-synuclein gene has been overexpressed, mutated or knocked out, and in vitro, such as in brain slices obtained from DJ-1 null mice [54, 55, 58].
4.2 Patch Clamp Capacitance and Postsynaptic Potential Measurement
Measurement of cell membrane capacitance via whole cell patch clamp provides another means to study exocytosis (Fig. 2B) [81]. Vesicles that fuse with the cell membrane cause an increase in membrane area, which can be detected as an increase in membrane capacitance (a capacitor being any material that separates two charged environments). Carrying out capacitance measurements in ‘Cell-Attached mode allows single exocytotic events to be resolved on a millisecond timescale. Unlike amperometry and voltammetry, patch clamping is not limited to cells that secrete oxidizable molecules. However, patch clamping is invasive and can disturb the intracellular environment. Most importantly, it is not applicable to the direct study of exocytosis in most types of neurons as the synapse is too small to place a microelectrode onto and obtain a seal. Recordings can be made at the neuronal soma but this places the microelectrode too electrically distant from the site of synaptic release, precluding direct measurement of presynaptic exocytosis. Such recordings are limited to neurons with relatively large synapses, such as the Calyx of Held and ribbon synapses in the inner ear and retina. Studies using these cells have provided a greater understanding of the mechanisms underlying neuronal exocytosis.
Another application of patch clamping is in the study of postsynaptic currents in neurons. Such experiments involve patch clamping a neuron in culture or in a brain slice preparation then applying electrical or pharmacological stimuli to neurons that synapse onto the patched neuron. Measuring the postsynaptic response elicited by the stimulated neuron provides insights into the exocytotic activity elicited in the presynaptic neuron [60]. This method is advantageous as it allows recordings to be obtained in a system that is relatively more representative of the in vivo environment. However, recording from postsynaptic neurons following a stimulus applied presynaptically in order to gauge presynaptic levels of exocytosis assumes that the applied experimental conditions have only affected presynaptic vesicle release and not the postsynaptic response. This is a popular assumption but one in which extreme care should be taken when making.
Insights into synaptic dysfunction and memory deficits in murine models of neurodegenerative diseases have been obtained by measuring field excitatory postsynaptic potentials. These measurements are obtained using field electrodes to detect action potentials from a population of neurons in hippocampal slices in response to electrical stimulation. Such measurements give insights into synaptic plasticity, learning and memory by providing a comparison of stimulus intensity and the speed and strength of the resulting postsynaptic potential [3, 5–7, 52, 65, 66].
4.3 Fluorescent Dyes and Live Cell Imaging
Fluorescent styryl compound dyes, commonly known as FM dyes (such as FM1-43], reversibly stain membranes and can be used to give a fluorescent readout of exocytosis and endocytosis. These compounds emit a low fluorescence in aqueous solutions which increases upon membrane binding. Stimulating cells in the presence of FM dyes in the extracellular solution results in dye becoming trapped in recycling vesicles, which can be visualized as punctate fluorescence within cells. Upon exocytosis, the trapped dye is released and the rate and the amount of decrease are indicative of the kinetics of exocytosis and the size of the vesicle recycling pool, respectively. Studies using FM dyes have yielded information on the rate and regulation of vesicle exocytosis and recycling in numerous cell types, such as frog neuromuscular junctions, hippocampal neurons and chromaffin cells [82–84].
pHluorins are another set of fluorescent molecules used to study exocytosis. These molecules consist of a mutant form of green fluorescent protein that displays pH-dependent fluorescence [85]. One such molecule is synapto-pHlourin consisting of a pHlourin molecule fused to VAMP2, a synaptic vesicle protein involved in SNARE formation and vesicle exocytosis [85]. Synapto-pHluorin fluorescence is quenched in the relatively low pH of the vesicle lumen (approximately 5.6]. During exocytosis, exposure of the vesicle lumen to the extracellular environment increases the luminal pH to approximately 7.4, resulting in increased fluorescence of the synapto-pHluorin and a visual indication of exocytosis [85]. Synapto-pHluorins have been used to study exocytosis and vesicle recycling in real time, in both astrocytes and neurons [85–88].
Fluorescent dyes are also available that specifically bind to Ca2+ within cells. These are important tools in the study of exocytosis as Ca2+ entry into the cell is the major physiological trigger of vesicle exocytosis and recycling. These dyes, such as fura-2, are fluorophores linked to calcium chelators. When the calcium chelator binds to calcium in a cell, the absorption spectrum of the fluorophore is altered, leading to fluorescence and a visual readout of changes in intracellular Ca2+ levels. This technique is useful in experiments using groups of cells, as the excitation of all cells present can be assessed simultaneously. However, it is not sensitive enough to detect small influxes of calcium that could still be sufficient to stimulate exocytosis [89, 90]. It is also technically difficult, but not impossible, to measure changes in intracellular Ca2+ levels in structurally limited areas such as synaptic boutons. Thus, imaging synaptic Ca2+ changes while simultaneously measuring neuronal exocytosis is not frequently performed.
5 Conclusion
Identifying the steps which instigate human neurodegenerative diseases is extremely complex and continues to elude researchers within the field. Studies described in this chapter provide evidence for an early disease course involving mitochondrial dysfunction leading to aberrant ROS and ATP levels. These abnormalities then lead to reduced synaptic activity and altered neuronal communication, underlying cognitive deficits and sometimes motor dysfunction, and possibly neuronal death. Whilst there is evidence supporting this hypothesis, it would be imprudent to believe it is the only compelling hypothesis on this topic or that it might be responsible for all facets of these diseases. The use of animal models for these diseases will likely prove to be invaluable in identifying the precise sequence of events leading to neurodegeneration and the subsequent verification of these findings in human samples. Proper use of techniques which enable neuronal exocytosis and vesicle recycling and trafficking to be measured will also play a vital part in increasing our understanding of the pathogenesis of such diseases. An improved understanding of the pathogenesis of neurodegenerative diseases will hopefully lead to treatments that are increasingly effective and disease specific.
References
Auerbach J, Segal M. Peroxide modulation of slow onset potentiation in rat hippocampus. Journal of Neuroscience 1997;17(22):8695–8701.
Murray C, Lynch M. Dietary supplementation with vitamin E reverses the age-related deficit in long term potentiation in dentate gyrus. Journal of Biological Chemistry 1998;273(20):12161–12168.
Jacobsen J, Wu C, Redwine J, et al. Early-onset behavioral and synaptic deficits in a mouse model of Alzheimer s disease. Proceedings of the National Academy of Sciences of the United States of America 2006;103(13):5161–5166.
Kleschevnikov A, Belichenko P, Villar A, Epstein C, Malenka R, Mobley W. Hippocampal long-term potentiation suppressed by increased inhibition in the Ts65Dn mouse, a genetic model of Down syndrome. Journal of Neuroscience 2004;24(37):8153–8160.
Murphy K, Carter R, Lione L, et al. Abnormal synaptic plasticity and impaired spatial cognition in mice transgenic for exon 1 of the human Huntington s disease mutation. Journal of Neuroscience 2000;20(13):5115–5123.
Oddo S, Caccamo A, Shepherd J, et al. Triple-transgenic model of Alzheimer s disease with plaques and tangles: intracellular Abeta and synaptic dysfunction. Neuron 2003;39(3):409–421.
Saura C, Choi S, Beglopoulos V, et al. Loss of presenilin function causes impairments of memory and synaptic plasticity followed by age-dependent neurodegeneration. Neuron 2004;42(1):23–36.
Siarey R, Stoll J, Rapoport S, Galdzicki Z. Altered long-term potentiation in the young and old Ts65Dn mouse, a model for Down syndrome. Neuropharmacology 1997;36(11–12):1549–1554.
Lu T, Pan Y, Kao S, et al. Gene regulation and DNA damage in the ageing human brain. Nature 2004;429(6994):883–891.
Lin M, Beal M. Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases. Nature 2006;443(7113):787–795.
Kamsler A, Segal M. Paradoxical actions of hydrogen peroxide on long-term potentiation in transgenic superoxide dismutase-1 mice. Journal of Neuroscience 2003;23(32):10359–10367.
Serrano F, Klann E. Reactive oxygen species and synaptic plasticity in the aging hippocampus. Ageing Research Reviews 2004;3(4):431–443.
McGahon B, Murray C, Horrobin D, Lynch M. Age-related changes in oxidative mechanisms and LTP are reversed by dietary manipulation. Neurobiology of Aging 1999;20(6):643–653.
Kamsler A, Segal M. Hydrogen peroxide modulation of synaptic plasticity. Journal of Neuroscience 2003;23(1):269–276.
Conforti L, Takimoto K, Petrovic M, Pongs O, Millhorn D. The pore region of the Kv1.2alpha subunit is an important component of recombinant Kv1.2 channel oxygen sensitivity. Biochemical and Biophysical Research Communications 2003;306(2):450–456.
Keating D, Rychkov G, Giacomin P, Roberts M. Oxygen-sensing pathway for SK channels in the ovine adrenal medulla. Clinical and Experimental Pharmacology and Physiology 2005;32(10):882–887.
Singh H, Ashley R. Redox regulation of CLIC1 by cysteine residues associated with the putative channel pore. Biophysical Journal 2006;90(5):1628–1638.
Zeng X, Xia X, Lingle C. Redox-sensitive extracellular gates formed by auxiliary beta subunits of calcium-activated potassium channels. Nature Structural Biology 2003;10(6):448–454.
Sen C, Packer L. Antioxidant and redox regulation of gene transcription. FASEB Journal 1996;10(7):709–720.
Klann E, Thiels E. Modulation of protein kinases and protein phosphatases by reactive oxygen species: implications for hippocampal synaptic plasticity. Progress in Neuro-Psychopharmacology and Biological Psychiatry 1999;23(3):359–376.
Giniatullin A, Darios F, Shakirzyanova A, Davletov B, Giniatullin R. SNAP25 is a pre-synaptic target for the depressant action of reactive oxygen species on transmitter release. Journal of Neurochemistry 2006;98(6):1789–1797.
Washbourne P, Cansino V, Mathews J, Graham M, Burgoyne R, Wilson M. Cysteine residues of SNAP-25 are required for SNARE disassembly and exocytosis, but not for membrane targeting. Biochemical Journal 2001;357(Pt 3):625–634.
Morton A, Faull R, Edwardson J. Abnormalities in the synaptic vesicle fusion machinery in Huntington s disease. Brain Research Bulletin 2001;56(2):111–117.
Sze C, Bi H, Kleinschmidt-DeMasters B, Filley C, Martin L. Selective regional loss of exocytotic presynaptic vesicle proteins in Alzheimer s disease brains. Journal of the Neurological Sciences 2000;175(2):81–90.
Hay J, Martin T. Resolution of regulated secretion into sequential MgATP-dependent and calcium-dependent stages mediated by distinct cytosolic proteins. Journal of Cell Biology 1992;119(1):139–151.
Holz R, Bittner M, Peppers S, Senter R, Eberhard D. MgATP-independent and MgATP-dependent exocytosis. Evidence that MgATP primes adrenal chromaffin cells to undergo exocytosis. Journal of Biological Chemistry 1989;264(10):5412–5419.
Dunn L, Holz R. Catecholamine secretion from digitonin-treated adrenal medullary chromaffin cells. Journal of Biological Chemistry 1983;258(8):4989–4993.
Sarafian T, Aunis D, Bader M. Loss of proteins from digitonin-permeabilized adrenal chromaffin cells essential for exocytosis. Journal of Biological Chemistry 1987;262(34):16671–16676.
Hay J, Fisette P, Jenkins G, et al. ATP-dependent inositide phosphorylation required for Ca2+-activated secretion. Nature 1995;374(6518):173–177.
Wiedemann C, Schafer T, Burger M. Chromaffin granule-associated phosphatidylinositol 4-kinase activity is required for stimulated secretion. EMBO Journal 1996;15(9):2094–2101.
Meunier F, Osborne S, Hammond G, et al. Phosphatidylinositol 3-kinase C2alpha is essential for ATP-dependent priming of neurosecretory granule exocytosis. Molecular Biology of the Cell 2005;16(10):4841–4851.
Larsen K, Schmitz Y, Troyer M, et al. Alpha-synuclein overexpression in PC12 and chromaffin cells impairs catecholamine release by interfering with a late step in exocytosis. Journal of Neuroscience 2006;26(46):11915–11922.
Guo X, Macleod G, Wellington A, et al. The GTPase dMiro is required for axonal transport of mitochondria to Drosophila synapses. Neuron 2005;47(3):379–393.
Verstreken P, Ly C, Venken K, Koh T, Zhou Y, Bellen H. Synaptic mitochondria are critical for mobilization of reserve pool vesicles at Drosophila neuromuscular junctions. Neuron 2005;47(3):365–378.
Chang D, Honick A, Reynolds I. Mitochondrial trafficking to synapses in cultured primary cortical neurons. Journal of Neuroscience 2006;26(26):7035–7045.
Chang D, Reynolds I. Differences in mitochondrial movement and morphology in young and mature primary cortical neurons in culture. Neuroscience 2006;141(2):727–736.
Li Z, Okamoto K, Hayashi Y, Sheng M. The importance of dendritic mitochondria in the morphogenesis and plasticity of spines and synapses. Cell 2004;119(6):873–887.
Nunomura A, Perry G, Aliev G, et al. Oxidative damage is the earliest event in Alzheimer disease. Journal of Neuropathology and Experimental Neurology 2001;60(8):759–767.
Pratico D, Uryu K, Leight S, Trojanoswki J, Lee V. Increased lipid peroxidation precedes amyloid plaque formation in an animal model of Alzheimer amyloidosis. Journal of Neuroscience 2001;21(12):4183–4187.
Reddy P, McWeeney S, Park B, et al. Gene expression profiles of transcripts in amyloid precursor protein transgenic mice: up-regulation of mitochondrial metabolism and apoptotic genes is an early cellular change in Alzheimer s disease. Human Molecular Genetics 2004;13(12):1225–1240.
Cirrito J, Yamada K, Finn M, et al. Synaptic activity regulates interstitial fluid amyloid-beta levels in vivo. Neuron 2005;48(6):913–922.
Kamenetz F, Tomita T, Hsieh H, et al. APP processing and synaptic function. Neuron 2003;37(6):925–937.
Ohyagi Y, Yamada T, Nishioka K, et al. Selective increase in cellular A beta 42 is related to apoptosis but not necrosis. Neuroreport 2000;11(1):167–171.
Gouras G, Almeida C, Takahashi R. Intraneuronal Abeta accumulation and origin of plaques in Alzheimer s disease. Neurobiology of Aging 2005;26(9):1235–1244.
Oddo S, Billings L, Kesslak J, Cribbs D, LaFerla F. Abeta immunotherapy leads to clearance of early, but not late, hyperphosphorylated tau aggregates via the proteasome. Neuron 2004;43(3):321–332.
Billings L, Oddo S, Green K, McGaugh J, LaFerla F. Intraneuronal Abeta causes the onset of early Alzheimer s disease-related cognitive deficits in transgenic mice. Neuron 2005;45(5):675–688.
Gunawardena S, Goldstein L. Disruption of axonal transport and neuronal viability by amyloid precursor protein mutations in Drosophila. Neuron 2001;32(3):389–401.
Betarbet R, Sherer T, MacKenzie G, Garcia-Osuna M, Panov A, Greenamyre J. Chronic systemic pesticide exposure reproduces features of Parkinson s disease. Nature Neuroscience 2000;3(12):1301–1306.
Sherer T, Betarbet R, Testa CM, et al. Mechanism of toxicity in rotenone models of Parkinson s disease. Journal of Neuroscience 2003;23(34):10756–10764.
Song DD, Shults CW, Sisk A, Rockenstein E, Masliah E. Enhanced substantia nigra mitochondrial pathology in human alpha-synuclein transgenic mice after treatment with MPTP. Experimental Neurology 2004;186(2):158–172.
Xu J, Kao S, Lee F, Song W, Jin L, Yankner B. Dopamine-dependent neurotoxicity of alpha-synuclein: a mechanism for selective neurodegeneration in Parkinson disease. Nature Medicine 2002;8(6):600–606.
Cabin D, Shimazu K, Murphy D, et al. Synaptic vesicle depletion correlates with attenuated synaptic responses to prolonged repetitive stimulation in mice lacking alpha-synuclein. Journal of Neuroscience 2002;22(20):8797–8807.
Murphy D, Rueter S, Trojanowski J, Lee V. Synucleins are developmentally expressed, and alpha-synuclein regulates the size of the presynaptic vesicular pool in primary hippocampal neurons. Journal of Neuroscience 2000;20(9):3214–3220.
Yavich L, Oksman M, Tanila H, et al. Locomotor activity and evoked dopamine release are reduced in mice overexpressing A30P-mutated human alpha-synuclein. Neurobiology of Disease 2005;20(2):303–313.
Yavich L, Tanila H, Vepsalainen S, Jakala P. Role of alpha-synuclein in presynaptic dopamine recruitment. Journal of Neuroscience 2004;24(49): 11165–11170.
Palacino J, Sagi D, Goldberg M, et al. Mitochondrial dysfunction and oxidative damage in parkin-deficient mice. Journal of Biological Chemistry 2004;279(18):18614–18622.
Chung K, Thomas B, Li X, et al. S-nitrosylation of parkin regulates ubiquitination and compromises parkin s protective function. Science 2004;304(5675):1328–1331.
Chen L, Cagniard B, Mathews T, et al. Age-dependent motor deficits and dopaminergic dysfunction in DJ-1 null mice. Journal of Biological Chemistry 2005;280(22):21418–21426.
Goldberg M, Fleming S, Palacino J, et al. Parkin-deficient mice exhibit nigrostriatal deficits but not loss of dopaminergic neurons. Journal of Biological Chemistry 2003;278(44):43628–43635.
Kitada T, Pisani A, Porter D, et al. Impaired dopamine release and synaptic plasticity in the striatum of PINK-1 deficient mice. Proceedings of the National Academy of Sciences of the United States of America 2007;104(27):11441–11446.
Mattiazzi M, D Aurelio M, Gajewski C, et al. Mutated human SOD1 causes dysfunction of oxidative phosphorylation in mitochondria of transgenic mice. Journal of Biological Chemistry 2002;277(33):29626–29633.
Damiano M, Starkov A, Petri S, et al. Neural mitochondrial Ca2+ capacity impairment precedes the onset of motor symptoms in G93A Cu/Zn-superoxide dismutase mutant mice. Journal of Neurochemistry 2006;96(5):1349–1361.
Sasaki S, Iwata M. Impairment of fast axonal transport in the proximal axons of anterior horn neurons in amyotrophic lateral sclerosis. Neurology 1996;47(2):535–540.
Sasaki S, Warita H, Abe K, Iwata M. Impairment of axonal transport in the axon hillock and the initial segment of anterior horn neurons in transgenic mice with a G93A mutant SOD1 gene. Acta Neuropathologica 2005;110(1):48–56.
Kuo J, Schonewille M, Siddique T, et al. Hyperexcitability of cultured spinal motoneurons from presymptomatic ALS mice. Journal of Neurophysiology 2004;91(1):571–575.
Spalloni A, Geracitano R, Berretta N, et al. Molecular and synaptic changes in the hippocampus underlying superior spatial abilities in pre-symptomatic G93A+/+ mice overexpressing the human Cu/Zn superoxide dismutase (Gly93 → ALA) mutation. Experimental Neurology 2006;197(2):505–514.
Milakovic T, Johnson G. Mitochondrial respiration and ATP production are significantly impaired in striatal cells expressing mutant huntingtin. Journal of Biological Chemistry 2005;280(35):30773–30782.
Gu M, Gash M, Mann V, Javoy-Agid F, Cooper J, Schapira A. Mitochondrial defect in Huntington s disease caudate nucleus. Annals of Neurology 1996;39(3):385–389.
Panov A, Gutekunst C, Leavitt B, et al. Early mitochondrial calcium defects in Huntington s disease are a direct effect of polyglutamines. Nature Neuroscience 2002;5(8):731–736.
Trushina E, Dyer R, Badger J, et al. Mutant huntingtin impairs axonal trafficking in mammalian neurons in vivo and in vitro. Molecular and Cellular Biology 2004;24(18):8195–8209.
Steffan J, Kazantsev A, Spasic-Boskovic O, et al. The Huntington s disease protein interacts with p53 and CREB-binding protein and represses transcription. Proceedings of the National Academy of Sciences of the United States of America 2000;97(12):6763–6768.
Bae BI, Xu H, Igarashi S, et al. p53 mediates cellular dysfunction and behavioral abnormalities in Huntington s disease. Neuron 2005;47(1):29–41.
Zhou Z, Misler S, Chow R. Rapid fluctuations in transmitter release from single vesicles in bovine adrenal chromaffin cells. Biophysical Journal 1996;70(3):1543–1552.
Alvarez de Toledo G, Fernández-Chacón R, Fernández J. Release of secretory products during transient vesicle fusion. Nature 1993;363(6429):554–558.
Bruns D, Jahn R. Real-time measurement of transmitter release from single synaptic vesicles. Nature 1995;377(6544):62–65.
Chen T, Luo G, Ewing A. Amperometric monitoring of stimulated catecholamine release from rat pheochromocytoma (PC12) cells at the zeptomole level. Analytical Chemistry 1994;66(19):3031–3035.
Huang L, Shen H, Atkinson M, Kennedy R. Detection of exocytosis at individual pancreatic beta cells by amperometry at a chemically modified microelectrode. Proceedings of the National Academy of Sciences of the United States of America 1995;92(21):9608–9612.
Leszczyszyn D, Jankowski J, Viveros O, Diliberto E, Near J, R W. Nicotinic receptor-mediated catecholamine secretion from individual chromaffin cells. Chemical evidence for exocytosis. Journal of Biological Chemistry 1990;265(25):14736–14737.
Pothos E, Davila V, Sulzer D. Presynaptic recording of quanta from midbrain dopamine neurons and modulation of the quantal size. Journal of Neuroscience 1998;18(11):4106–4118.
Wightman R, Jankowski J, Kennedy R, et al. Temporally resolved catecholamine spikes correspond to single vesicle release from individual chromaffin cells. Proceedings of the National Academy of Sciences of the United States of America 1991;88(23):10754–10758.
Neher E, Sakmann B. Single-channel currents recorded from membrane of denervated frog muscle fibres. Nature 1976;260(5554):799–802.
Betz W, Bewick G. Optical analysis of synaptic vesicle recycling at the frog neuromuscular junction. Science 1992;255(5041):200–203.
Ryan T, Reuter H, Wendland B, Schweizer F, Tsien R, Smith S. The kinetics of synaptic vesicle recycling measured at single presynaptic boutons. Neuron 1993;11(4):713–724.
Smith C, Betz W. Simultaneous independent measurement of endocytosis and exocytosis. Nature 1996;380(6574):531–534.
Miesenböck G, De Angelis D, Rothman J. Visualizing secretion and synaptic transmission with pH-sensitive green fluorescent proteins. Nature 1998;394(6689):192–195.
Sankaranarayanan S, De Angelis D, Rothman J, Ryan T. The use of pHluorins for optical measurements of presynaptic activity. Biophysical Journal 2000;79(4):2199–2208.
Sankaranarayanan S, Ryan T. Real-time measurements of vesicle-SNARE recycling in synapses of the central nervous system. Nature Cell Biology 2000;2(4):197–204.
Bowser D, Khakh B. Two forms of single-vesicle astrocyte exocytosis imaged with total internal reflection fluorescence microscopy. Proceedings of the National Academy of Sciences of the United States of America 2007;104(10):4212–4217.
Dai Z, Peng H. Fluorescence microscopy of calcium and synaptic vesicle dynamics during synapse formation in tissue culture. The Histochemical Journal 1998;30(3):189–196.
Wong R. Calcium imaging and multielectrode recordings of global patterns of activity in the developing nervous system. The Histochemical Journal 1998;30(3):217–229.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2009 Humana Press, a part of Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Zanin, M.P., Keating, D.J. (2009). Exocytosis, Mitochondrial Injury and Oxidative Stress in Neurodegenerative Diseases. In: Veasey, S. (eds) Oxidative Neural Injury. Contemporary Clinical Neuroscience. Humana Press. https://doi.org/10.1007/978-1-60327-342-8_4
Download citation
DOI: https://doi.org/10.1007/978-1-60327-342-8_4
Published:
Publisher Name: Humana Press
Print ISBN: 978-1-60327-341-1
Online ISBN: 978-1-60327-342-8
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)